| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/28/2005 | US20050164928 Kallikrein-inhibitor therapies |
| 07/28/2005 | US20050164927 Aqueous sustained-release formulations of proteins |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164925 Treatment of gastroparesis |
| 07/28/2005 | US20050164924 Method and composition for treating skin wounds with epidermal growth factor |
| 07/28/2005 | US20050164923 Use of soluble fgl2 as an immunosuppresant |
| 07/28/2005 | US20050164922 Octapeptides, cyclic peptides; treating Cushings Syndrome, gonadotropinoma, hyperparathyroidism, Paget's disease, irritable bowel syndrome, pancreatitis, Crohn's Disease; inhibiting the secretion of growth hormone, insulin; imaging cells |
| 07/28/2005 | US20050164921 7-Methoxy-2,4-disubstituted quinoline derivatives |
| 07/28/2005 | US20050164920 Compounds that modulate neuronal growth and their uses |
| 07/28/2005 | US20050164919 Bactericides; peptide antibiotics |
| 07/28/2005 | US20050164918 Protein has N terminal hairpin domain and subsequent four kringle domains; hepatocyte growth factor antagonists; angiogenesis inhibitors; deletion or substitution mutants; antitumor and antimetastatic biodrugs |
| 07/28/2005 | US20050164917 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2005 | US20050164916 Glycopeptide phosphonate derivatives |
| 07/28/2005 | US20050164915 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 07/28/2005 | US20050164914 erectile dysfunction, and female sexual dysfunction; metallopeptide contains aromatic amino acid side chain moieties and does not bind any melanocortin receptor; combination therapy with phosphodiesterase inhibitor or melanocortin receptor MC4-R agonist |
| 07/28/2005 | US20050164913 Mixture of ionic surfactant, chelate compound and solvent preferable water; bactericide against grampositive, gramnegative bacteria |
| 07/28/2005 | US20050164911 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 07/28/2005 | US20050164910 Decomposing gelatin or collagen using collegenase; purification by gel filtration; antiallergens |
| 07/28/2005 | US20050164909 Methods and reagents for treating inflammation and fibrosis |
| 07/28/2005 | US20050164908 Neuroprotective complex for treatment of cerebral ischemia and injury |
| 07/28/2005 | US20050164907 Comparing level or bioactivity of Wnt protein/PCP pathway component, frizzled related protein gene product of the Wnt/PCP pathway, or FRP of the Wnt/PCP pathway with the level in a normal sample |
| 07/28/2005 | US20050164906 Inhibitors of the Mitogen Activated Protein Kinases (MAPKs) pathway activated by Ras/Raf complex using GILZ (glucocorticoid-Induced Leucine Zipper) protein related compounds as inhibitors of Raf/Ras-mediated signal transduction; anticarcinogenic agents |
| 07/28/2005 | US20050164368 Transgenic, grampositive bacteria comprising expression vector coding viricidal agent for use in treatment and prevention of gastrointestinal disorders in infants |
| 07/28/2005 | US20050164367 Protein |
| 07/28/2005 | US20050164366 Tissue plasminogen activator-like protease |
| 07/28/2005 | US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection |
| 07/28/2005 | US20050164348 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 07/28/2005 | US20050164344 Metabotropic glutamate receptor regulator for use in identifying modulator of channel-mediated intracellular calcium mobilization and treatment of nervous system disorders |
| 07/28/2005 | US20050164342 Cloned glutamic acid decarboxylase |
| 07/28/2005 | US20050164339 Purified enzyme mixture capable of effecting dehydration and cyclization of precursor peptide; medicines; food processing; bioagriculture; drugs and cytotoxicity |
| 07/28/2005 | US20050164337 Using metal affinity chromatography to isolate beta -conglycinin-enriched soluble protein fraction for use in treatment of hyperlipidemias; anticholesterol agents |
| 07/28/2005 | US20050164327 Using human embryonic kidney cells as bioreactor in identifying modulator of brain protease; treating alzheimers disease; enzyme inhibitors; drug screening |
| 07/28/2005 | US20050164324 Systems, methods and kits for characterizing phosphoproteomes |
| 07/28/2005 | US20050164323 Identifying modulators of protein kinase c for use as treatments of respiratory system disorders; antiasthmatic agents |
| 07/28/2005 | US20050164312 IL1-beta: a new target for myeloma therapy |
| 07/28/2005 | US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | US20050164294 Beta-secretase enzyme compositions and methods |
| 07/28/2005 | US20050164288 Using g protein coupled receptor to identifying modulator for use in treatment and prevention of pain; antinociceptive agents |
| 07/28/2005 | US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/28/2005 | US20050164280 Twisted gastrulation (TSG) polypeptide for designing drugs to regulate hematopoietic stem cell generation; treating blood disorders |
| 07/28/2005 | US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same |
| 07/28/2005 | US20050164277 Novel human hemicentin proteins and polynucleotides encoding the same |
| 07/28/2005 | US20050164271 Antisense agents for treatment of adrenocorticotropic hormone dysregulation; gene expression inhibition; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 07/28/2005 | US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164257 Lymphocytic epitope of substituted/variant polypeptide for use in generating hypoallergenic and/or hyperallergenic compositions; directed protein evolution |
| 07/28/2005 | US20050164256 Treating and/or preventing cornary heart defects via administration of forkhead transcription factor; gene therapy |
| 07/28/2005 | US20050164251 Novel human transporter proteins and polynucleotides encoding the same |
| 07/28/2005 | US20050164248 Compositions isolated from bovine tissues and methods for their use |
| 07/28/2005 | US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid |
| 07/28/2005 | US20050164245 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 07/28/2005 | US20050164240 Eucaryotic transcription factor antisense nucleotides for detection and treatment of cancer; antitumor agents |
| 07/28/2005 | US20050164233 Compositions, kits and methods for identification and modulation of type I diabetes |
| 07/28/2005 | US20050164224 Cancers such as lymphomas, carcinoma, ovarian cancer, melanoma, colorectal cancer, prostate cancer, lung cancer, bladder cancer |
| 07/28/2005 | US20050164212 Modulation of gene expression using DNA-RNA hybrids |
| 07/28/2005 | US20050164206 For use in gene therapy |
| 07/28/2005 | US20050164202 Nucleotide sequences coding junctophilin-like polypeptides (JPL) to prevent ad treat cell proliferative disorders; antitumor agents; anticarcinogenic agents; tissue targeted therapy; immunotherapeutics |
| 07/28/2005 | US20050164201 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof |
| 07/28/2005 | US20050164194 Growth regulating proteins |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050164183 Adipocyte differentiation-associated gene and protein |
| 07/28/2005 | US20050164173 Using antibiotic cocktail/mixture to treat prokaryotic invasion pathologies; microbiocides; bactericides; reduced oxidative stress and disease prevention |
| 07/28/2005 | US20050164163 Helicase inhibitors; enzyme inhibitor; viricides agent; mimetics |
| 07/28/2005 | US20050163888 dairy products containing Lactobacillus gasseri used for prophylaxis and/or therapy of gastrointestinal disorders such as ulcers |
| 07/28/2005 | US20050163825 Lactoferrin-treated filament materials |
| 07/28/2005 | US20050163822 Biodegradable bio-absorbable material for clinical practice and method for producing the same |
| 07/28/2005 | US20050163817 Biomatrix structural containment and fixation systems and methods of use thereof |
| 07/28/2005 | US20050163809 Remedy for hypermyotonia |
| 07/28/2005 | US20050163799 Ditetics; useful for decreasing the amount of insulin necessary for the treatment of diabetes; Fc immunoglobulin region, derivative or analog fused to the N-terminal portion of the OB protein, derivative or analog |
| 07/28/2005 | US20050163798 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF) to patient in need thereof, wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and a multimerizing component; eye disorders |
| 07/28/2005 | US20050163794 Immunological herpes simplex virus antigens and methods for use thereof |
| 07/28/2005 | US20050163793 Methods for recovering peptides from stress protein-peptide complexes |
| 07/28/2005 | US20050163790 Method of treatment and agents useful for same |
| 07/28/2005 | US20050163788 Prevention and treatment of amyloidogenic disease |
| 07/28/2005 | US20050163786 Compounds and methods for modulating adhesion molecule function |
| 07/28/2005 | US20050163784 cdc42 is a pivotal molecule in tumors and that up- or downregulation of this component can play a role in stopping cancerous outgrowth; activity increased by administering small molecules of non-hydrolyzable GTP analogues of cdc-42 |
| 07/28/2005 | US20050163781 uses of inhibitors against hypoxia-induced genes for the manufacture of a medicament to prevent and/or to suppress post-operative/post-wounding adhesions formation; peritoneal or pelvic cavities resulting from wound, surgery, infection, inflammation or trauma |
| 07/28/2005 | US20050163780 Administering antagonist of a GP39, selected from an antibody which specifically bind GP39, soluble CD40 and soluble CD40 fusion proteins |
| 07/28/2005 | US20050163779 smooth muscle growth inhibitory composition comprising adipose tissue-specific secretory factor apM1 (adipose most abundant gene transcript 1) as an active ingredient; diagnostic agent comprising an antibody against the adipose tissue-specific secretory factor apM1 |
| 07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/28/2005 | US20050163775 selectively deplete B cells from a mixed population of cells by contacting with a BAFF antagonist and a CD20 antigen binding antibody; immunoadhesin; treating B cell malignancies or a B-cell regulated autoimmune disorder |
| 07/28/2005 | US20050163772 B7S1: an immune modulator |
| 07/28/2005 | US20050163771 Administering N-acetyl-cysteine; anda compound for reversing a high level of high affinity receptor mediated oxytocin effect; administering compounds for reversing at least two biochemical conditions associated with preterm labor |
| 07/28/2005 | US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 07/28/2005 | US20050163767 useful as a diagnostic marker or a drug target for bronchial asthma, chronic obstructive pulmonary disease; isolated antibody which specifically binds to a specific protein belonging to the chitinase family |
| 07/28/2005 | US20050163764 oral administration and mucosal administration and wherein the gastrointestinal injury is treated; bacterial infection and cancer treatments that can cause tissue damage |
| 07/28/2005 | US20050163761 isogenic or autologous body cells that express at least one angiogenetic or anti-angiogenetic protein; suitable for the production of transplants and implants |
| 07/28/2005 | US20050163760 sustained delivery of a molecule to the central nervous system; bioavailability; population of cells enriched in hematopoietic stem or progenitor or stem cells capable of migrating to the CNS upon administration |
| 07/28/2005 | US20050163755 Methods and compositions related to 1-caldesmon |
| 07/28/2005 | US20050163754 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same |
| 07/28/2005 | US20050163752 Human interferon-beta formulations |
| 07/28/2005 | US20050163751 Synergistic mixture with compounds such as interferon, paclitaxel or P-16; side effect reduction |
| 07/28/2005 | US20050163749 Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture |
| 07/28/2005 | US20050163748 Wall structure permits suturing and/or attaching to tissues; may contain growth factor, anitbodies, cytokines |
| 07/28/2005 | US20050163747 Heteromultimeric TNF ligand family members |
| 07/28/2005 | US20050163746 Heat shock proteins (HSP) activate lymphocytes to produce immunomodulatory cytokines and influence cytokines, chemokines, and surface antigens; drug screening |
| 07/28/2005 | US20050163744 Novel method for down-regulation of amyloid |
| 07/28/2005 | US20050163731 Skin depigmenting compositions comprising adapalene and at least one depigmenting active agent |
| 07/28/2005 | US20050163728 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash or gum patch |